NC

Nimish Chudgar

Active Director Director DIN 00212400
DIN 00212400 First appointment May 1985 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 16 historical roles
Total affiliations 22 Since May 1985
Shareholding value Locked Premium profile
Directorship timeline
First appointment 31 May 1985
Active appointments 20
Total timeline records 22

Appointment history

Since 1985
Sm Herbals Private Limited Director · 2019 - 2026
Current
Intas Lifesciences Private Limited Director · 2015 - 2026
Current
Occura Eyecare Private Limited Director · 2014 - 2026
Current
Current
Arron Fresh Private Limited Director · 2012 - 2026
Current
Celestial Biologicals Limited Director · 2011 - 2026
Current
Cytas Research Limited Director · 2011 - 2026
Current
Oncology Services India Limited Director · 2011 - 2026
Current
Intas Medi Devices Limited Director · 2010 - 2026
Current
Intas Biopharmaceuticals Limited Director · 2006 - 2026
Current
Accord Healthcare Limited Director · 2003 - 2026
Current
Intas Pharma Limited. Managing Director · 2002 - 2026
Current
Astron Packaging Limited Director · 2001 - 2026
Current
Astron Research Limited Director · 2001 - 2026
Current
Andre Laboratories Limited Director · 2001 - 2026
Current
Indus Biotherapeutics Limited Director · 2000 - 2026
Current
Prime Paediatrics Private Limited Director · 1998 - 2026
Current
Intas Enterprise Private Limited Director · 1994 - 2026
Current
Equatorial Private Limited Director · 1994 - 2026
Current
Intas Pharmaceuticals Limited Managing Director · 1985 - 2026
Current
Penem Pharmachemi Private Limited Director · 2023 - 2023
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available